Specifics of infertility treatment in women with premature ovarian failure

Czech version

Authors: M. Poláková
Authors‘ workplace: Gennet, Praha
Published in: Ceska Gynekol 2023; 88(2): 131-134
Category: Review Article
doi: https://doi.org/10.48095/cccg2023131

Overview

Premature ovarian failure (POF, POI – premature ovarian insufficiency) is a serious situation for a woman with reproductive plans that more or less precludes having her own biological child. In addition to the lack of functional oocytes in the ovaries, it is also a premature lack of sex hormones, which has an overall negative effect on health. The article guides us through care both in the clinic of the gynecologist and through treatment in the center of reproductive medicine. The diagnosis and treatment of POF illustrates some endocrinological principles and connections.

Keywords:

infertility – hormone replacement therapy – premature ovarian failure

Sources

1. Rogerio A. Premature ovarian failure. In: Strauss JF, Barbieri RL, Dokras A et al (eds). Yen & Jaffe’s reproductive endocrinology. 7th ed. UK, London: Elsevier: 2014: 188–191, 308–339.

2. Fait T, Kushniruk N. Předčasné ovariální selhání v každodenní praxi. Gyn Por 2022; 6 (1): 22–24.

3. Li H, Chang T, Mu H et al. Case report: birth achieved after effective ovarian stimulation combined with dexamethasone in a patient with resistant ovary syndrom. J Ovarian Res 2022; 15 (1): 42. doi: 10.1186/s13048-022-00976-4.

4. Webber L, Davies M, Anderson R et al. ESHRE Giudeline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31 (5): 926–937. doi: 10.1093/humrep/dew027.

5. Ferin M, Jewelewicz R, Warren M (eds). Menstruační cyklus. Praha: Grada Publishing 1997: 21–37.

6. Mardešič T. Antimülleriánský hormon v moderní reprodukční medicíně. Gyn Por 2019; 3 (4): 2013–2019.

7. Gulati SC, Van Poznak C. Pregnancy after bone marrow transplantation. J Clin Oncol 1998; 16 (5): 1978–1985. doi: 10.1200/JCO.1998.16.5.1978.

8. Abban G, Johnson J. Stem cell support oogenesis in the human. Hum Reprod 2009; 24 (12): 2974–2978. doi: 10.1093/humrep/dep281.

9. Křepelka P. Estetrol a možnosti jeho klinického využití. Ceska Gynekol 2021; 86 (3): 217–221. doi: 10.48095/cccg2021217.

10. Chansel-Debordeaux L, Rault E, Depuydt C et al. Successful live birth after in vitro maturation treatment in a patient with autoimmune premature ovarian failure: a case report and review of the literature. Gynecol Endocrinol 2021; 37 (12): 1138–1142. doi: 10.1080/095 13590.2021.1928065.

11. Ročenka Asistovaná reprodukce v ČR 2017. Praha: ÚZIS ČR 2019: 37–49.

12. Cibula D, Henzl MR, Živný J (eds). Základy gynekologické endokrinologie. Praha: Grada 2002: 301–302.